Boston BioLife will host an exclusive three-day Functional Longevity Medicine Summit in Phoenix from February 27 through March 1, 2026, convening leading clinicians, scientists, and health innovators to advance the real-world future of precision-based care. The immersive event moves beyond theoretical discussions to focus on actionable clinical and business strategies shaping the next era of preventive and personalized medicine.
With longevity medicine accelerating at an unprecedented pace, the summit will spotlight four critical pillars driving the field forward: the molecular science behind aging and cellular decline, advanced functional diagnostics guiding modern clinical decisions, breakthrough therapeutic strategies translating science into patient outcomes, and sustainable business models for longevity-focused medical practices. More than 100 forward-thinking medical and wellness professionals are expected to attend as they seek to stay ahead in one of healthcare's fastest-evolving sectors.
The summit features an impressive lineup of respected thought leaders including Dr. Kien Vuu, physician and longevity expert; Bill Andrews, pioneering telomere researcher; Brian Bradley, performance strategist known for work with Tony Robbins; Patrick Porter, founder of BrainTap and neurotechnology innovator; and Amie Hornaman, thyroid and metabolic health specialist. Exhibitors will showcase cutting-edge technologies and therapeutics, including therapeutic plasma exchange programs from Lifespan Edge, alongside solutions from Life Armor, Pneuma Nitric Oxide, InHale and Integrative Peptides.
National and niche outlets including NDNR.com, the Next Generation Podcast Network, the Biohacking Index and Top Doctor Magazine are slated to cover the gathering, along with regional media. The event has also attracted former NFL player and entrepreneur AC Caswell, founder of Million Dollar Mingle Celebrity Charity Events. In partnership with Project One Cause, the summit will support charitable initiatives benefiting Scottsdale-area communities.
Joseph Krieger, founder and CEO of Boston BioLife, says this summit reflects a larger healthcare inflection point, as providers increasingly pivot from reactive treatment models toward proactive, data-driven longevity strategies. Clinicians and industry professionals interested in attending can learn more and secure tickets through BostonBioLife.com, with a Spring Functional Longevity Summit tentatively scheduled for Washington D.C. from June 4th through 7th, 2026.
The implications of this gathering extend beyond the conference itself, representing a significant shift in how healthcare approaches aging. As precision medicine meets functional longevity strategies, this summit could accelerate the adoption of personalized aging interventions that move healthcare from sick care to smart care. For medical professionals, this represents both clinical advancement and business opportunity as patient demand grows for proactive aging solutions. For the broader public, the developments discussed at this summit could eventually translate to more accessible, personalized approaches to healthy aging that extend quality of life.
